Capital Analysts, LLC Becton Dickinson & CO Transaction History

Capital Analysts, LLC

  • $2.45 Billion
  • Q3 2024

A detailed history of Capital Analysts, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Capital Analysts, LLC holds 36,566 shares of BDX stock, worth $8.23 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
36,566
Previous 35,225 3.81%
Holding current value
$8.23 Million
Previous $8.23 Million 7.09%
% of portfolio
0.36%
Previous 0.36%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$221.47 - $242.41 $296,991 - $325,071
1,341 Added 3.81%
36,566 $8.82 Million
Q2 2024

Aug 14, 2024
BUY
$225.07 - $246.17 $215,166 - $235,338
956 Added 2.79%
35,225 $8.23 Million
Q1 2024

May 14, 2024
BUY
$233.45 - $247.73 $383,791 - $407,268
1,644 Added 5.04%
34,269 $8.48 Million
Q4 2023

Jan 30, 2024
BUY
$232.24 - $267.23 $150,027 - $172,630
646 Added 2.02%
32,625 $7.96 Million
Q3 2023

Nov 13, 2023
BUY
$254.9 - $283.59 $536,309 - $596,673
2,104 Added 7.04%
31,979 $8.27 Million
Q2 2023

Aug 11, 2023
BUY
$238.39 - $265.32 $422,427 - $470,147
1,772 Added 6.31%
29,875 $7.89 Million
Q1 2023

May 05, 2023
BUY
$229.71 - $259.35 $169,066 - $190,881
736 Added 2.69%
28,103 $6.96 Million
Q4 2022

Feb 08, 2023
BUY
$218.29 - $256.91 $278,319 - $327,560
1,275 Added 4.89%
27,367 $6.96 Million
Q3 2022

Nov 14, 2022
BUY
$51.03 - $264.23 $88,639 - $458,967
1,737 Added 7.13%
26,092 $5.81 Million
Q2 2022

Aug 12, 2022
BUY
$234.74 - $275.42 $251,876 - $295,525
1,073 Added 4.61%
24,355 $6.01 Million
Q1 2022

May 12, 2022
BUY
$243.64 - $270.48 $267,029 - $296,446
1,096 Added 4.94%
23,282 $6.19 Million
Q4 2021

Feb 10, 2022
BUY
$230.08 - $250.94 $324,872 - $354,327
1,412 Added 6.8%
22,186 $5.58 Million
Q3 2021

Nov 04, 2021
BUY
$232.72 - $256.47 $215,033 - $236,978
924 Added 4.65%
20,774 $5.11 Million
Q2 2021

Nov 15, 2021
SELL
$232.65 - $254.58 $215,201 - $235,486
-925 Reduced 4.45%
19,850 $4.83 Million
Q2 2021

Aug 05, 2021
BUY
$232.65 - $254.58 $488,332 - $534,363
2,099 Added 11.24%
20,775 $5.05 Million
Q1 2021

May 17, 2021
BUY
$232.09 - $256.88 $362,292 - $400,989
1,561 Added 9.12%
18,676 $4.54 Million
Q4 2020

Feb 16, 2021
BUY
$221.92 - $245.94 $142,694 - $158,139
643 Added 3.9%
17,115 $4.28 Million
Q3 2020

Nov 12, 2020
SELL
$215.77 - $276.76 $23,950 - $30,720
-111 Reduced 0.67%
16,472 $3.83 Million
Q2 2020

Aug 07, 2020
SELL
$219.9 - $263.41 $155,249 - $185,967
-706 Reduced 4.08%
16,583 $3.97 Million
Q1 2020

May 08, 2020
BUY
$195.69 - $279.01 $76,319 - $108,813
390 Added 2.31%
17,289 $3.97 Million
Q4 2019

Feb 12, 2020
SELL
$236.45 - $266.82 $15,369 - $17,343
-65 Reduced 0.38%
16,899 $4.6 Million
Q3 2019

Nov 12, 2019
BUY
$230.58 - $256.08 $5,072 - $5,633
22 Added 0.13%
16,964 $4.29 Million
Q2 2019

Aug 13, 2019
SELL
$217.4 - $246.08 $185,659 - $210,152
-854 Reduced 4.8%
16,942 $4.27 Million
Q1 2019

May 13, 2019
SELL
$206.05 - $248.17 $75,414 - $90,830
-366 Reduced 2.02%
17,796 $4.44 Million
Q4 2018

Feb 13, 2019
SELL
$204.73 - $257.93 $3,070 - $3,868
-15 Reduced 0.08%
18,162 $4.09 Million
Q3 2018

Nov 07, 2018
BUY
$233.07 - $256.0 $54,538 - $59,904
234 Added 1.3%
18,177 $0
Q2 2018

Aug 03, 2018
SELL
$208.1 - $233.85 $3,329 - $3,741
-16 Reduced 0.09%
17,943 $0
Q1 2018

May 14, 2018
BUY
$205.46 - $240.27 $12,738 - $14,896
62 Added 0.35%
17,959 $3.89 Million
Q4 2017

Feb 14, 2018
BUY
$189.0 - $222.64 $3.33 Million - $3.92 Million
17,607 Added 6071.38%
17,897 $3.83 Million
Q4 2017

Feb 12, 2018
SELL
$189.0 - $222.64 $3.24 Million - $3.81 Million
-17,126 Reduced 98.33%
290 $65,000
Q3 2017

Nov 06, 2017
BUY
$186.89 - $198.9 $3.25 Million - $3.46 Million
17,416
17,416 $3.41 Million

Others Institutions Holding BDX

# of Institutions
1,735
Shares Held
250M
Call Options Held
690K
Put Options Held
787K
View Full List

About BECTON DICKINSON & CO

BDX Quotes by TradingView
  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Capital Analysts, LLC Portfolio

Follow Capital Analysts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Analysts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email